Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-24

Clinical Trial Update: Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by the University of California, Irvine is evaluating whether sodium bicarbonate alters 24-hour urine parameters in people with hypoci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: University of California, Irvine | Conditions: Uric Acid Stones | Phase 1 | Status: RECRUITING